Actively Recruiting
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-12-17
60
Participants Needed
1
Research Sites
131 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.
CONDITIONS
Official Title
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- IBS-D patients and healthy volunteers meeting diagnostic criteria
- Aged between 18 and 70
- Have not taken antibiotics, steroids, hormones, Chinese herbal preparations, microecological preparations, or probiotics in the past week
- Patients willing to sign informed consent and receive treatment; volunteers willing to provide blood, urine, stool, and other samples
You will not qualify if you...
- Serious heart, liver, kidney, blood, nervous system, or mental diseases
- Other digestive system organic diseases or systemic diseases affecting digestive motility
- Need to continue drugs affecting gastrointestinal function
- History of drug allergy or severe food allergy
- Under 18 or over 75 years old; pregnant or lactating women
- Severe negative life events during treatment
- Currently undergoing psychotherapy
- No intention to cooperate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100091
Actively Recruiting
Research Team
F
Fengyun Wang, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here